Clinical
RSSArticles
-
STI Quarterly: Initiative launched to raise condom awareness
-
STI Quarterly: FDA approves new test for chlamydia/gonorrhea
The Food and Drug Administration (FDA) has given clearance to Cepheid of Sunnyvale, CA, to market its Xpert CT/NG test. -
STI Quarterly: STI snapshot: Chlamydia leads in national rates — Young most at risk
According to a just-released analysis of the latest national sexually transmitted infection (STI) surveillance data, 1.4 million new cases of chlamydia were reported in the United States in 2011. -
Washington Watch: Abortion coverage alters for servicewomen
In one of its final acts, the lame-duck 112th Congress did something unprecedented over its two-year term: It expanded access to publicly financed abortion, ever so slightly. -
STI Quarterly: Initiative launched to raise condom awareness
-
Clinicians continue unneeded pelvic exams
Results of a new national survey of obstetricians and gynecologists (OB/GYNs) show that many physicians mistakenly believe a routine annual bimanual pelvic examination is important in screening for ovarian cancer. -
Clinical Briefs in Primary Care
Risks and Benefits of an Extended 10-year Tamoxifen Regimen for Breast Cancer; Is There More Pro than Con in Probiotics in Critically Ill Adults?; Are OSA Outcomes Better in the Hands of Sleep Specialists than Primary Care Clinicians?;Inhaled Steroids Increase Risk of TB in COPD Patients; The ASH Position Paper on Orthostatic Hypotension -
Pharmacology Watch: Do Statins Prevent Parkinson’s Disease?
-
Clinical Briefs in Primary Care
Evidence-based updates in primary care medicine By Louis Kuritzky, MD -
Diminishing Returns with Long-term Steroids in COPD Exacerbations
Five days of steroid treatment was as effective as 14 days of treatment in preventing repeat exacerbations of COPD in patients presenting to the emergency department with COPD exacerbations.